Duchesnay Inc. is seeking Health Canada's approval for ospemifene for the treatment of moderate to severe dyspareunia and vaginal dryness, symptoms of vulvar and vaginal atrophy, a component of genitourinary syndrome of menopause
Morning Star,
/CNW Telbec/ - Duchesnay Inc. has filed a New Drug Submission (NDS) with Health Canada for a once-daily oral ospemifene tablet…